A message from our CEO. At Carevive, we wholeheartedly support the need for change in this country. A change to achieve a society where equality, opportunities, and safety are rights that are undeniably provided to all.
CareviveJune 10, 2020
This project represents the first assessment of Oral Medication (OM) adherence in patients with AML.
CareviveMay 14, 2020
Authors: Ashley Leak Bryant PhD, RN1 ; Ya-Ning Chan RN, MSN1 ; Jaime Richardson RN, BSN1; Matthew Foster, MD1 ; Debra Wujcik, PhD, RN2 1 The University of North Carolina at Chapel Hill School of Nursing; 2 North Carolina Cancer Hospital, Lineberger Comprehensive Cancer Center, Division of Hematology and Oncology, The University of North Carolina at Chapel Hill 3 Carevive…
CareviveMay 5, 2020
Authors: Debra Wujcik, PhD, RN1 ; Susie Owenby, RN1 ; Moh’d Khushman MD2 ; Daniel Cameron, MD2; Thomas Butler, MD2; Cathy Tinnea RN2, Austin Cadden MPH2, Jennifer Pierce, MD2, Sachin Gopalkrishna Pai, MD2 1 Carevive Systems, Inc, Miami, FL 2 University of South Alabama Mitchell Cancer Institute Background Treatment of lung cancer has seen a paradigm shift in recent years.…
CareviveMay 1, 2020
We are delighted to announce that Carevive was selected to be a part of Silicon Valley Health Batch X Program at Plug and Play. The Plug and Play Health team evaluated over 900 startups across the globe, and approximately 30 companies were selected by their Corporate Partners to present at Plug and Play’s Selection Day on February 27, 2020, at…
CareviveMarch 9, 2020
Release Date: 3/4/2020 Expiration Date: 3/3/2021 Estimated Time to Complete the Activity: 45 minutes Physicians – Maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses – 0.7 contact hours (0.4 pharmacotherapy) The goals of this initiative are to (1) close existing cancer clinician competency gaps regarding newly approved and emerging therapies for Triple-Negative Breast Cancer TNBC and the management…
CareviveMarch 4, 2020
Carevive Systems, a leading oncology-focused health technology company, announced today that it has received Series C funding from new investors Philips Health Technology Ventures and Debiopharm Innovation Fund.
CareviveFebruary 13, 2020
Release Date: 11/8/2019 Expiration Date: 11/9/2020 Physicians – Maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses – 1.2 contact hours (0.4 pharmacotherapy) The goal of this project is to identify the variety of symptoms relevant to patients receiving treatment for AML and test the electronic Patient Reported Outcomes (ePRO) tool in the clinical setting. A certified educational training…
CareviveNovember 27, 2019
Release Date: 9/23/2019 Expiration Date: 9/22/2020 Physicians – Maximum of 1.5 AMA PRA Category 1 Credits™ Registered Nurses – 1.4 contact hours (0.4 pharmacotherapy) The goal of this project is to evaluate the effectiveness of a shared decision-making (SDM) model in advancing care outcomes as well as clinician and patient engagement in managing multiple myeloma (MM). We will evaluate the…
CareviveSeptember 23, 2019
